75000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 75010 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 75020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 75030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 75040 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss 2 link:presentationLink link:calculationLink link:definitionLink 75050 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 75060 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 995455 - Disclosure - Description of Business and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 995465 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995475 - Disclosure - Fair Value Measurements and Marketable Securities link:presentationLink link:calculationLink link:definitionLink 995485 - Disclosure - Prepaid Expenses and Other Current Assets link:presentationLink link:calculationLink link:definitionLink 995495 - Disclosure - Fixed Assets link:presentationLink link:calculationLink link:definitionLink 995505 - Disclosure - Accrued Expenses link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - Stockholders' Equity and Stock Options link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - Related Party link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 995555 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 995565 - Disclosure - Fair Value Measurements and Marketable Securities (Tables) link:presentationLink link:calculationLink link:definitionLink 995575 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 995585 - Disclosure - Fixed Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 995595 - Disclosure - Accrued Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 995605 - Disclosure - Stockholders' Equity and Stock Options (Tables) link:presentationLink link:calculationLink link:definitionLink 995615 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 995625 - Disclosure - Description of Business and Basis of Presentation - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995635 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995645 - Disclosure - Summary of Significant Accounting Policies - Summary of Significant Expense (Details) link:presentationLink link:calculationLink link:definitionLink 995655 - Disclosure - Summary of Significant Accounting Policies - Summary of Significant Expense (Parenthetical) (Details) link:presentationLink link:calculationLink link:definitionLink 995665 - Disclosure - Fair Value Measurements and Marketable Securities - Summary of Cash Equivalents and Marketable Securities (Detail) link:presentationLink link:calculationLink link:definitionLink 995675 - Disclosure - Fair Value Measurements and Marketable Securities - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995685 - Disclosure - Fair Value Measurements and Marketable Securities - Summary of Marketable Debt Securities (Details) link:presentationLink link:calculationLink link:definitionLink 995695 - Disclosure - Prepaid Expenses and Other Current Assets - Schedule of Prepaid Expenses and Other Current Assets (Detail) link:presentationLink link:calculationLink link:definitionLink 995705 - Disclosure - Fixed Assets - Schedule of Fixed Assets, Net (Detail) link:presentationLink link:calculationLink link:definitionLink 995715 - Disclosure - Fixed Assets - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995725 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Detail) link:presentationLink link:calculationLink link:definitionLink 995735 - Disclosure - Stockholders Equity and Stock Options - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995745 - Disclosure - Stockholders Equity and Stock Options - Assumptions used to Determine Fair Value of Stock Options Granted (Detail) link:presentationLink link:calculationLink link:definitionLink 995755 - Disclosure - Stockholders Equity and Stock Options - Summary of Stock Option Activity (Detail) link:presentationLink link:calculationLink link:definitionLink 995765 - Disclosure - Stockholders Equity and Stock Options - Summary of Restricted Stock Units (Details) link:presentationLink link:calculationLink link:definitionLink 995775 - Disclosure - Stockholders Equity and Stock Options - Summary of Stock-Based Compensation Expense (Detail) link:presentationLink link:calculationLink link:definitionLink 995785 - Disclosure - Commitments and Contingencies - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995795 - Disclosure - Commitments and Contingencies - Schedule of Maturities of Lease Liabilities Due Under Lease Agreements (Detail) link:presentationLink link:calculationLink link:definitionLink 995805 - Disclosure - Commitments and Contingencies - Schedule of Maturities of Lease Liabilities Due Under Lease Agreements (Detail) 2 link:presentationLink link:calculationLink link:definitionLink 995815 - Disclosure - Related Party - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink Weighted average grant date fair value, Restricted stock units vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Weighted average exercise price, Forfeited/Expired Weighted average exercise price, Options forfeited/expired Entity Incorporation, State or Country Code Entity Incorporation State Country Code Lab Space [Member] Lab Space [Member] Lab space. Undesignated preferred stock, shares issued Preferred Stock, Shares Issued, Total Preferred Stock, Shares Issued Preferred stock, shares issued Increase (Decrease) in Accounts Payable, Total Increase (Decrease) in Accounts Payable Accounts payable Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Supplemental disclosure of non-cash investing and financing activities: Plan Name [Axis] Plan Name Investments in continuous loss position for 12 months or longer Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer Entity Current Reporting Status Entity Current Reporting Status Cash proceeds from exercises of warrants Proceeds from Warrant Exercises Operating Expenses [Abstract] Operating expenses: Fair Value, Inputs, Level 2 [Member] Significant Other Observable Inputs (Level 2) [Member] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Common Stock, Shares Authorized Common stock, shares authorized Amount of payment due upon reaching milestone. Milestone Payment Amount Milestone payments Lease term commencement date. Lease Term Commencement Date Lease term commencement date Massachusetts [Member] MASSACHUSETTS Product and Service [Axis] Document Fiscal Period Focus Document Fiscal Period Focus Entity Shell Company Entity Shell Company Legal Entity of Counterparty, Type [Axis] Legal Entity of Counterparty, Type Other Accrued Liabilities, Current Accrued other Segment Reporting, Policy [Policy Text Block] Segment Information Cash and Cash Equivalents, at Carrying Value, Ending Balance Cash and Cash Equivalents, at Carrying Value, Beginning Balance Cash and Cash Equivalents, at Carrying Value, Total Cash and Cash Equivalent Cash and cash equivalents Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Employees and directors. Employees and Directors [Member] Employees and Directors [Member] Common Stock, Shares, Issued, Total Common Stock, Shares, Issued Common stock, shares issued Common stock, shares issued Statement [Table] Statement [Table] Restricted Cash, Noncurrent Restricted cash Leased assets obtained in exchange for new operating lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Interest Receivable Accrued interest receivable Weighted-average grant date fair value of options granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Statement [Line Items] Statement [Line Items] Vest over four years, Vest Over Four Years [Member] Vest Over 4 Years [Member] Entity Filer Category Entity Filer Category Beginning of Study [Member] Beginning of study. Liabilities and Equity Total liabilities and stockholders’ equity Payables and Accruals [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Weighted average exercise price, Exercisable as of September 30, 2025 Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset PENNSYLVANIA Pennsylvania [Member] Liability Reserve Estimate, Policy [Policy Text Block] Liquidity and Capital Resources Amount of asset related to consideration paid in advance for costs related to research and development. Prepaid Research And Development Expenses Prepaid research and development expenses Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Marketable securities with remaining maturities greater than two years The value of marketable securities with remaining maturities greater than two years, as of the balance sheet date. Marketable Securities With Remaining Maturities Greater Than Two Years Shares Issued, Price Per Share Share price per share Long-term marketable securities Debt Securities, Available-for-Sale, Noncurrent Geographical [Domain] Geographical Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options Unvested And Expected To Vest, Weighted Average Grant Date Fair Value Per share or unit weighted-average fair value of awards that are unvested and expected to vest under share-based payment arrangement. Excludes share and unit options. Weighted average grant date fair value, Unvested and expected to vest as of September 30, 2025 Accounts Receivable, Allowance for Credit Loss, Beginning Balance Accounts Receivable, Allowance for Credit Loss, Ending Balance Accounts Receivable, Allowance for Credit Loss Allowance for credit loss Additional Paid in Capital, Common Stock, Ending Balance Additional Paid in Capital, Common Stock, Beginning Balance Additional Paid in Capital, Common Stock Additional paid-in capital Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Share-Based Compensation Arrangement by Share-Based Payment Award, Terms of Award Share-based compensation arrangement by share-based payment award, description Vesting [Domain] Vesting Options to purchase shares of common stock granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Number of shares, Options granted Dividends Payable Dividend paid Earnings Per Share, Basic, Total Earnings Per Share, Basic Net loss per share, basic Area of office space. Area Of Office Space Area of office space NonRule 10b51 Arr Modified Flag NonRule10b51ArrModifiedFlag. Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Number of shares, Outstanding Number of shares, Outstanding Summary of Marketable Securities Schedule of Available-for-Sale Securities Reconciliation [Table Text Block] Liabilities, Current Total current liabilities Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: First Anniversary [Member] First Anniversary [Member] First anniversary. Technical Operations Expense [Member] Technical operations expense. Technical operations [Member] The entire disclosure for prepaid expenses and other current assets. Prepaid Expenses And Other Current Assets [Text Block] Prepaid Expenses and Other Current Assets Accounting Standards Update [Axis] Equity, Attributable to Parent [Abstract] Stockholders’ equity: Entity Small Business Entity Small Business Increase (Decrease) in Accrued Liabilities, Total Increase (Decrease) in Accrued Liabilities Accrued expenses Retained Earnings (Accumulated Deficit), Ending Balance Retained Earnings (Accumulated Deficit), Beginning Balance Retained Earnings (Accumulated Deficit), Total Retained Earnings (Accumulated Deficit) Accumulated deficit Other Commitments [Line Items] Other Commitments [Line Items] Net proceeds from underwritten public offering Proceeds from Issuance Initial Public Offering Organization, Consolidation and Presentation of Financial Statements [Abstract] Summary of significant accounting policies. Summary Of Significant Accounting Policies [Line Items] Summary Of Significant Accounting Policies [Line Items] Lease Contractual Term [Axis] Lease Contractual Term Leases [Abstract] Amendment Flag Amendment Flag Product and Service [Domain] Class of Warrant or Right, Number of Securities Called by Warrants or Rights Issuance of warrants Warrants issued Per unit amount of prefunded warrant issued. Warrants Issued Price Per Share Warrants price per share Net Loss Per Share Earnings Per Share, Policy [Policy Text Block] Liabilities and Equity [Abstract] Liabilities and Stockholders’ Equity Entity Address, Postal Zip Code Entity Address, Postal Zip Code Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Operating activities Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description Common Stock [Member] Common Stock [Member] Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average exercise price, Options granted Interest receivable Interest Receivable, Current Lessee, Operating Lease, Liability, to be Paid, Year Three Year ended December 31, 2028 Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Less: Accumulated depreciation Amortization of Debt Discount (Premium) Amortization of premium on marketable securities Debt Securities, Available-for-Sale [Line Items] Schedule Of Available For Sale Securities [Line Items] Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Entity Address, Address Line One Entity Address, Address Line One Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false] Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Assumptions used to Determine Fair Value of Stock Options Granted Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV Income Tax, Policy [Policy Text Block] Income Taxes Investment Type [Axis] Investment Type Operating Lease, Right-of-Use Asset Operating lease right-of-use assets Annual base rent Sublease Annual Base Rent Sublease annual base rent. Purchases of marketable securities Payments to Acquire Debt Securities, Available-for-Sale Skin Cells [Member] Skin cells. Document Type Document Type Additional Office [Member] Additional Office [Member] Additional office. Entity Central Index Key Entity Central Index Key Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Net increase in cash, cash equivalents and restricted cash Subsequent Event Type [Domain] Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Total potentially dilutive shares Option Indexed to Issuer's Equity [Axis] Common Stock, Par or Stated Value Per Share Common stock, par value per share Common stock, par value Accounting Standards Update [Domain] Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Total other comprehensive gain (loss) Operating Costs and Expenses, Total Operating Costs and Expenses Cost related to FARA Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Weighted average remaining contractual term, outstanding Debt Securities, Available-for-Sale, Amortized Cost Amortized Cost Amortized Cost Fair Value Marketable securities Debt Securities, Available-for-Sale Debt Securities, Available-for-Sale, Total Vest one year. Vest One Year [Member] Vest One Year [Member] Exercise of stock options, shares Number of shares, Exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Description of sales agreement.. Sales Agreement Description Sales agreement, description Marketable Securities Marketable Securities, Total Marketable securities Accrued Liabilities, Current Accrued expenses Total accrued expenses Vesting of restricted stock units Stock Issued During Period, Value, Restricted Stock Award, Gross Current Fiscal Year End Date Current Fiscal Year End Date Document Quarterly Report Document Quarterly Report Entity Address, State or Province Entity Address, State or Province Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Number of shares, Outstanding Number of shares, Outstanding Outstanding shares Offering Costs Included In Accounts Payable And Accrued Expense The amount of offering costs that were incurred, but not yet paid, during the period. Offering costs included in accounts payable and accrued expense Undesignated preferred stock, shares outstanding Preferred Stock, Shares Outstanding, Ending Balance Preferred Stock, Shares Outstanding, Beginning Balance Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Comprehensive Income (Loss), Net of Tax, Attributable to Parent Total comprehensive loss Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Gross Unrealized Gains Research and Development Expense, Policy [Policy Text Block] Research and Development Costs 2020 Equity Incentive Plan [Member] Two Thousand Twenty Equity Incentive Plan [Member] Two thousand twenty equity incentive plan. Geographical Geographical [Axis] Minimum level of maximum number of shares allowed to be issued The minimum threshold number of shares used to determine the maximum number of shares that may be issued under the Plan. Share Based Compensation Arrangement By Share Based Payment Award Threshold Number Of Shares Allowed To Issue Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Summary of Stock-Based Compensation Expense Exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Accrued Expenses Nature of Expense [Axis] Subsequent Event [Member] MTS Health Partners. M T S Health Partners [Member] MTS Health Partners [Member] Carrying value as of the balance sheet date of obligations incurred through that date and payable for expenses related to research and development. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accrued Research And Development Expense Current Accrued research and development expenses Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Increase in shares reserved for future issuance Other Assets, Noncurrent, Total Other Assets, Noncurrent Other assets Short-term marketable securities Debt Securities, Available-for-Sale, Current Fair Value Exercise of warrants, shares Stock Issued During Period Shares Exercise of Warrants Number of shares of issued as a result of the exercise of warrants. Antidilutive Securities [Axis] Antidilutive Securities Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Stock option vesting percentage Award vesting Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Aggregate intrinsic value, Vested and expected to vest as of September 30, 2025 Amount of payment due for milestones that have been achieved Milestone Liability Milestone payments due Related Party Transaction [Axis] AOCI Attributable to Parent [Member] Accumulated Other Comprehensive Gain (Loss) [Member] Other Commitments [Table] Other Commitments [Table] Preferred Stock, Value, Issued, Ending Balance Preferred Stock, Value, Issued, Beginning Balance Preferred Stock, Value, Issued, Total Preferred Stock, Value, Issued Preferred stock; $0.001 par value per share; 5,000,000 shares authorized as of September 30, 2025 and December 31, 2024; no shares issued and outstanding as of September 30, 2025 and December 31, 2024 U.S. Government Securities [Member] U.S. Government Securities [Member] U.S. Government securities. Minimum [Member] Minimum [Member] Weighted average grant date fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted average grant date fair value, Restricted stock units granted Financial Instrument [Axis] Assets, Current [Abstract] Current assets: Fair Value, Inputs, Level 3 [Member] Significant Unobservable Inputs (Level 3) [Member] Segment Reporting [Abstract] Interim Period, Costs Not Allocable [Domain] Liabilities, Current [Abstract] Current liabilities: Related Party Transactions [Abstract] Research and Development Related Stock Compensation Expense [Member] Research and development related stock compensation expense. Research and Development Related Stock Compensation Expense [Member] Shares, Outstanding Ending balance, shares Beginning balance, shares Lessee, Operating Lease, Renewal Term Lease extension period Commitments and contingencies (See Note 8) Commitments and Contingencies Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Weighted average grant date fair value, balance Weighted average grant date fair value, balance General and Administrative Expense [Member] General and Administrative [Member] Operating Lease, Liability, Total Operating Lease, Liability Operating lease liability Present value of lease liabilities Forecast [Member] Forecast [Member] Nomlabofusp Support Expense [Member] Nomlabofusp support expense. Nomlabofusp Support [Member] Prior ATM Agreement At The Market Equity Distribution Agreement [Member] At the market equity distribution agreement. The amount that may be deducted from consideration due to Licensor 2 as a percentage of consideration paid to Licensor 1, whereby Licensor 1 is the identified party. License Agreement Consideration Deduction Percentage License agreement consideration deduction percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms Weighted average remaining contractual term, Outstanding as of September 30, 2025 Capital Expenditures Incurred but Not yet Paid Purchases of property and equipment included in accounts payable and accrued expenses Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Lease Contractual Term [Domain] Lease Contractual Term Weighted Average Number of Shares Outstanding, Basic, Total Weighted Average Number of Shares Outstanding, Basic Weighted average common shares outstanding, basic Scenario [Axis] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Aggregate intrinsic value, exercisable as of September 30, 2025 Follow On Offering with Over Allotment Option [Member] Follow On Offering with Over Allotment Option. Underwritten Public Offering [Member] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset Proceeds from Issuance of Private Placement Gross proceeds Related Party Related Party Transactions Disclosure [Text Block] APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Stock-based compensation expense The fee for services as a percentage of gross proceeds resulting from the sale of shares of common stock under a sales agreement. Percentage Of Compensation For Services Equal To Gross Proceeds Percentage of compensation for services equal to gross proceeds Wake forest university health sciences and indiana university research and technology corporation. Wake Forest University Health Sciences And Indiana University Research And Technology Corporation [Member] WFUHS and IU [Member] Equity, Attributable to Parent Ending balance Beginning balance Total stockholders’ equity Sixth sublease year member Sixth Sublease Year [Member] Sixth Sublease Year Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options Unvested And Expected To Vest, Aggregate Intrinsic Value Intrinsic value of awards that are unvested and expected to vest under share-based payment arrangement. Excludes share and unit options. Aggregate intrinsic value, Unvested and expected to vest as of September 30, 2025 Undesignated preferred stock, par value Preferred Stock, Par or Stated Value Per Share Preferred stock, par value per share Preferred stock, par value Basis of Accounting, Policy [Policy Text Block] Basis of Presentation Statement of Stockholders' Equity [Abstract] Use of Estimates, Policy [Policy Text Block] Use of Estimates Underwritten Public Offering [Member] Over-Allotment Option [Member] Leasehold Improvements [Member] Leasehold Improvements [Member] Entity Address, Address Line Two Entity Address, Address Line Two Fair Value Measurements and Marketable Securities Fair Value Disclosures [Text Block] 2022 Equity Distribution Agreement [Member] Two Thousand Twenty Two Equity Distribution Agreement [Member] Two thousand twenty two equity distribution agreement member. Schedule of Accrued Liabilities [Table Text Block] Schedule of Accrued Expenses Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] Plan Name [Domain] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Business Description and Basis of Presentation [Text Block] Description of Business and Basis of Presentation Buccal Cells [Member] Buccal cells. Related and Nonrelated Parties [Axis] Accounting Standards Update [Extensible Enumeration] Entity Address, City or Town Entity Address, City or Town Number of Reportable Segments Number of reportable segment Security Exchange Name Security Exchange Name Prepaid Expense and Other Assets [Abstract] Property, Plant and Equipment, Gross, Ending Balance Property, Plant and Equipment, Gross, Beginning Balance Property, Plant and Equipment, Gross, Total Property, Plant and Equipment, Gross Fixed assets, gross Debt Securities, Available-for-Sale, Unrealized Gain (Loss), Total Debt Securities, Available-for-Sale, Unrealized Gain (Loss) Unrealized gains or losses related to available-for-sale investments Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Number of shares, Vested and expected to vest as of September 30, 2025 Antidilutive Securities, Name [Domain] Antidilutive Securities, Name Stockholders' Equity Note [Abstract] Executive Officer [Member] Statistical Measurement [Domain] Statistical Measurement Class of Warrant or Right, Exercise Price of Warrants or Rights Warrants exercise price Assets, Current Total current assets Share-Based Payment Arrangement, Expense Total stock-based compensation expense Stock-based compensation expense Document Period End Date Document Period End Date Title and Position [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Number of shares, Exercisable as of September 30, 2025 First Sublease Year [Member] First sublease year member. First Sublease Year [Member] Statement of Financial Position [Abstract] Restricted Stock Units (RSUs) [Member] Restricted Stock Units (RSUs) Restricted Stock Units [Member] Vesting [Axis] Vesting Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Other comprehensive loss: Liabilities Total liabilities From Exercise of Warrants [Member] From Exercise of Warrants [Member] From exercise of warrants. Financial Instruments [Domain] The minimum annual royalty payment that is required under a contractual arrangement. Minimum Annual Royalty Obligation Annual royalty pay obligation Lessee, Operating Lease, Liability, to be Paid, Year Two Year ended December 31, 2027 Restricted Cash, Total Restricted Cash Letter of credit Wake Forest University Health Sciences (WFUHS) [Member] Wake Forest University Health Sciences [Member] WFUHS [Member] Restricted Stock [Member] Restricted Stock [Member] The maximum number of shares that may be added annually to the threshold number of shares issued under the Plan, as a percentage of the shares issued and outstanding on the last day of the immediately preceding fiscal year. Share Based Compensation Arrangement By Share Based Payment Award Additional Shares Percentage Of Outstanding Stock Percentage of outstanding shares Weighted average common shares outstanding, diluted Weighted Average Number of Shares Outstanding, Diluted, Total Weighted Average Number of Shares Outstanding, Diluted Entity File Number Entity File Number OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Unrealized gain (loss) on marketable securities Accounting Standards Update 2023-07 [Member] ASU 2023-07 [Member] Cover [Abstract] Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Total prepaid expenses and other current assets Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Number of shares, Restricted stock units forfeited Investments [Domain] Investments Tabular disclosure of the carrying amounts of prepaid expenses and other current assets. Schedule Of Prepaid Expenses And Other Current Assets Table [Text Block] Schedule of Prepaid Expenses and Other Current Assets Scenario [Domain] US Treasury Bills [Member] US Treasury Securities [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Maximum number of shares that may be issued under stock option incentive plan Number of Operating Segments Number of operating segment Sale of Stock Sale of Stock [Domain] General and Administrative Expense, Total General and Administrative Expense General and administrative Number of shares, Forfeited/Expired Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Total Number of shares, Options forfeited/expired Short-Term Debt, Type [Domain] Short-term Debt, Type Operating Lease, Expense Lease expenses Number of executive officers granted performance-based awards Number Of executive officers granted performance based awards. Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Weighted average exercise price, Vested and expected to vest as of September 30, 2025 Common Stock Equivalents. Common Stock Equivalents [Member] Common Stock Equivalents [Member] Property, Plant and Equipment, Useful Life Property Plant And Equipment Useful Life Fixed assets, useful life Short-term Debt, Type Short-Term Debt, Type [Axis] New Accounting Pronouncements, Policy [Policy Text Block] Recently Issued and Adopted Accounting Pronouncements Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Schedule of Maturities of Lease Liabilities Due Under Lease Agreements Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Summary of Restricted Stock Units Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, not separately disclosed. Other Prepaid Expense And Other Current Assets Other prepaid expenses and other assets Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Vesting period of stock option Depreciation, Total Depreciation Depreciation expense General and Administrative Related Stock Compensation Expense [Member] General and administrative related stock compensation expense. General and Administrative Related Stock Compensation Expense [Member] Lessee, Operating Lease, Term of Contract Operating lease term Common Stock, Shares, Outstanding, Ending Balance Common Stock, Shares, Outstanding, Beginning Balance Common Stock, Shares, Outstanding Common stock, shares outstanding Common stock outstanding Operating Lease, Liability, Current Operating lease liabilities, current Document Transition Report Document Transition Report Operating Expenses Total operating expenses Operating expenses Research and Development Expense, Total Research and Development Expense Research and development Research and development expense Asset Impairment Charges, Total Asset Impairment Charges Impairment losses on investment At-the-market equity offering program. At The Market Equity Offering Program [Member] ATM Offering Program [Member] Statement of Cash Flows [Abstract] Issuance of common stock, net Stock Issued During Period, Value, New Issues Share-Based Payment Arrangement, Option, Activity [Table Text Block] Summary of Stock Option Activity Development Expense [Member] Development expense. Development [Member] Equity [Text Block] Stockholders' Equity and Stock Options Computer Equipment [Member] Computer Equipment [Member] Commercial [Member] Commercial Expense [Member] Commercial Expense [Member] Net loss Net loss Net loss Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Aggregate intrinsic value, outstanding Aggregate intrinsic value of outstanding options granted The amount of depreciation expenses recognized in the period, excluding depreciation for leased assets as part of a sublease agreement. Depreciation Expense Excluding Leased Assets Depreciation expense Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Dividend yield Assets [Abstract] Assets Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk-free interest rate Increase (Decrease) in Prepaid Expense and Other Assets, Total Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Mean Level HV at Baseline Percentage The amount of HV at baseline, as a percentage. Percentage of increasing from mean level Document Fiscal Year Focus Document Fiscal Year Focus Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Investing activities: Accounts Payable, Current, Total Accounts Payable, Current Accounts payable Research and Development Expense [Member] Research and Development [Member] Research and Development Expenses [Member] Increase (Decrease) in Other Noncurrent Assets Other assets Incentive stock options member. Incentive Stock Options [Member] Incentive Stock Options [Member] Fair Value Disclosures [Abstract] Commitments and Contingencies Disclosure [Abstract] Lessee, Operating Lease, Liability, to be Paid, Year One Year ended December 31, 2026 Proceeds net of issuance costs Sale of Stock, Consideration Received on Transaction Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Unrecognized compensation expense Assets, Fair Value Disclosure Total cash equivalents and marketable securities Sale of Stock [Axis] Sale of Stock Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Investing activities Private Placement [Member] Private Placement [Member] Rule 10b51 Arr Modified Flag Rule 10b51 Arr Modified Flag. Title of 12(b) Security Title of 12(b) Security Schedule of Segment Reporting Information, by Segment [Table] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Weighted average grant date fair value, Restricted stock units forfeited Money Market Funds [Member] Money Market Funds [Member] Related and Nonrelated Parties [Domain] Allowance for credit loss Debt Securities, Available-for-Sale, Allowance for Credit Loss Debt Securities, Available-for-Sale, Allowance for Credit Loss, Ending Balance Debt Securities, Available-for-Sale, Allowance for Credit Loss, Beginning Balance Debt Securities, Available-for-Sale, Allowance for Credit Loss, Total Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Three months ending December 31, 2025 Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Property, Plant and Equipment [Table Text Block] Schedule of Fixed Assets, Net Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted average exercise price, balance Weighted average exercise price, balance Fair Value, Recurring and Nonrecurring [Table] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Payment for license agreements. Payment for license agreements Additional Paid-in Capital [Member] Additional Paid-in Capital [Member] Statement of Income Location, Balance [Axis] Income Statement Location Change in Accounting Principle, Accounting Standards Update, Adoption Date Trading Symbol Trading Symbol Property, Plant and Equipment Disclosure [Text Block] Fixed Assets Related Party Transaction [Table] Security Deposit Liability Lease security deposits letters of credit Directors [Member] Director [Member] Subsequent Event Type [Axis] Disclosure of accounting policy for the assessment of the ability to continue as a going concern. Going Concern Policy [Text Block] Going Concern Assessment Employee-related Liabilities, Current, Total Employee-related Liabilities, Current Accrued payroll and related expenses Proceeds from exercise of stock options and warrants Proceeds From Stock Options And Warrant Exercises The cash inflow from the exercise of options under share-based payment arrangements and from holders exercising their stock warrants. Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Financing activities: Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Expected term (in years) Lessee, Operating Lease, Liability, to be Paid Total lease payments Lessee, Operating Lease, Liability, Undiscounted Excess Amount Less: imputed interest Equity Components [Axis] Equity Components Employees [Member] Employees. Employees [Member] Lease expense Cash and Non Cash Operating Lease Expense The amount of lease expense, both cash and non-cash, related to operating leases. Nonoperating Income (Expense), Total Nonoperating Income (Expense) Other income, net Other income, net Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options Unvested And Expected To Vest, Weighted Average Remaining Contractual Terms Weighted average remaining contractual term for equity-based awards excluding options that are unvested and expected to vest, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Weighted average remaining contractual term, Unvested and expected to vest as of September 30, 2025 Equity Component [Domain] Equity Component Prepaid Insurance Prepaid insurance Public Offering [Member] Common Stock, Voting Rights Common stock voting rights From Prior Plans [Member] From Prior Plans [Member] From Prior Plans [Member] Maximum [Member] Maximum [Member] Statistical Measurement [Axis] Statistical Measurement Weighted average exercise price, Exercised Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Common Stock, Value, Issued, Ending Balance Common Stock, Value, Issued, Beginning Balance Common Stock, Value, Issued, Total Common Stock, Value, Issued Common stock, $0.001 par value per share; 115,000,000 shares authorized as of September 30, 2025 and December 31, 2024; 85,590,392 and 63,815,065 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively Office [Member] Office [Member] Office. Term of plan The term of the plan. Share Based Compensation Arrangement By Share Based Payment Award Duration Track-FA program. Track F A Program [Member] Track-FA program [Member] Equipment [Member] Lab Equipment [Member] Legal Entity Type of Counterparty [Domain] Legal Entity Type of Counterparty Comprehensive loss: Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent, Total Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent Unrealized gain (loss) on marketable debt securities Unrealized loss on marketable debt securities Unrealized gain (loss) on marketable securities Office and Lab. Office and Lab [Member] Office And Lab [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected volatility Undesignated preferred stock, shares authorized Preferred Stock, Shares Authorized Preferred stock, shares authorized Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Unvested And Expected To Vest Outstanding Number The number of equity-based payment instruments, excluding stock (or unit) options, that are unvested and expected to vest as of the balance sheet date. Number of shares, Unvested and expected to vest as of September 30, 2025 Related Party Transaction [Line Items] The amount of expense recognized during the period related to milestones. Such amount may include, but is not limited to, amounts due for attainment of milestones as well as deductions granted as part of a license agreement. Milestone Expenses Milestone expenses Entity Registrant Name Entity Registrant Name Indiana University Research and Technology Corporation. Indiana University Research And Technology Corporation [Member] IU [Member] Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Gross Unrealized Losses Gross Unrealized Losses Income tax benefit Income Tax Expense (Benefit) Income Tax Expense (Benefit), Total Proceeds from Issuance of Common Stock Proceeds from issuance of common stock, net of issuance costs Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Accumulated Other Comprehensive Income (Loss), Net of Tax, Total Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive gain Payments to Acquire Property, Plant, and Equipment, Total Payments to Acquire Property, Plant, and Equipment Purchase of property and equipment Purchases of property and equipment Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Number of shares, Restricted stock units granted Assets Total assets Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Weighted average remaining contractual term, Exercisable as of September 30, 2025 Income Statement [Abstract] Inducement Stock. Inducement Stock [Member] Inducement Stock [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Aggregate intrinsic value, Outstanding as of September 30, 2025 Share-Based Payment Arrangement [Policy Text Block] Stock-Based Compensation The potential aggregate gross sales proceeds available under a sales agreement to sell shares of the Company's common stock. Aggregate Gross Sales Proceeds Under Sales Agreement Aggregate sale of shares of our common stock Aggregate sale of shares of our common stock Amount of lessee's undiscounted obligation for lease payment for operating lease due after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Lessee Operating Lease Liability Payments Due After Year Four Thereafter Issuance of common stock, net, shares Issuance of common stock Stock Issued During Period, Shares, New Issues Number of shares, Restricted stock units vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Net loss per share, diluted Earnings Per Share, Diluted, Total Earnings Per Share, Diluted Summary of Significant Expense Schedule of Segment Reporting Information, by Segment [Table Text Block] Final sublease year Final Sublease Year [Member] Final Sublease Year [Member] Title and Position [Domain] Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration] City Area Code City Area Code At the market offering member. At The Market Offering [Member] ATM Offering [Member] Intangible Assets, Finite-Lived, Policy [Policy Text Block] Patent Costs The amount of depreciation expense recognized in the period related to leased assets as part of a sublease agreement. Depreciation Expenses Related to Sublet Assets Depreciation expenses related to sublet assets Operating Lease, Weighted Average Remaining Lease Term Weighted average remaining lease term in years Real Estate [Domain] Segment Reporting Information [Line Items] Vesting of restricted stock units, shares Stock Issued During Period, Shares, Restricted Stock Award, Gross Lease Expiration Date Lease term expiration date Letter of Credit [Member] Letter of Credit Property, Plant and Equipment, Net, Beginning Balance Property, Plant and Equipment, Net, Ending Balance Property, Plant and Equipment, Net Property and equipment, net Fixed assets, net Cash, cash equivalents and restricted cash at end of period Cash, cash equivalents and restricted cash at beginning of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total Corporate Bond Securities [Member] Corporate Bonds [Member] Loss from operations Operating Income (Loss) Retained Earnings [Member] Accumulated Deficit [Member] Share-based Payment Arrangement, Noncash Expense, Total Share-Based Payment Arrangement, Noncash Expense Stock-based compensation expense Proceeds from issuance of common stock and prefunded warrants to purchase common stock, net of offering costs. Proceeds From Issuance Common Stock And Warrants Net Offering Costs Proceeds from issuance common stock and warrants net offering costs Friedreich's Ataxia Research Alliances. Friedreich's Ataxia Research Alliances [Member] Friedreich's Ataxia Research Alliances [Member] Costs incurred during the period related to the issuance of stock and warrants. Stock And Warrant Issuance Transaction Costs Transaction cost Operating Lease, Weighted Average Discount Rate, Percent Weighted average discount rate Operating Lease, Liability, Noncurrent Operating lease liabilities Fair Value, Inputs, Level 1 [Member] Quoted Prices in Active Markets, (Level 1) [Member] Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Financing activities Change in Accounting Principle, Accounting Standards Update, Adopted [true false] Office Sublease [Member] Office Sublease [Member] Office Sublease U.S. Government and Agency Securities [Member] US Government Corporations and Agencies Securities [Member] U.S Government and Agency Securities (due within 1 year) [Member] Debt Securities, Available-for-Sale [Table] Entity Interactive Data Current Entity Interactive Data Current Statement of Income Location, Balance [Domain] Income Statement Location Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Operating activities: Furniture and Fixtures [Member] Furniture and Fixtures [Member] Summary of significant accounting policies. Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Real Estate, Type of Property [Axis] Real Estate, Type of Property January 2025 PSU Awards [Member] January Twenty Twenty Five Performance-Based Restricted Stock Unit Awards [Member] January twenty twenty five performance-based restricted stock unit awards. Option Indexed to Issuer's Equity, Type [Domain] Option Indexed to Issuer's Equity, Type Entity Tax Identification Number Entity Tax Identification Number Fair Value, Assets Measured on Recurring and Nonrecurring Basis [Table Text Block] Summary of Cash Equivalents and Marketable Securities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale Maturities of marketable securities Patient and Caregiver Awareness Events [Member] Patient and Caregiver Awareness Events [Member] Patient and caregiver awareness events. Local Phone Number Local Phone Number Related Party Transaction [Domain] July Two Thousand Twenty Five Public Offering [Member] July two thousand twenty five public offering. July 2025 Public Offering [Member] End of Study [Member] End of study. Accounting Policies [Abstract] Lessee, Operating Lease, Liability, to be Paid, Year Four Year ended December 31, 2029 Commercial Paper [Member] Commercial Paper [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Shares available for grant Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Unrecognized compensation expense recognized period Cash and cash equivalents Cash, Cash Equivalents, and Short-Term Investments Cash, Cash Equivalents, and Short-Term Investments, Total Entity Emerging Growth Company Entity Emerging Growth Company Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Weighted average remaining contractual term, Vested and expected to vest as of September 30, 2025